# 10Years-Retinoblastoma
This study analyzes the clinical presentation and survival rates of patients with retinoblastoma using retrospective clinical data from 2012 to 2021, collected at the National Eye Center (NEC) in Indonesia, a middle-income country. The aim is to improve survival outcomes and align them more closely with those observed in other middle-income nations.

